Clinica Universidad de Navarra, Universidad de Navarra

unav.edu

Total trials

159

Active

34

Phase 3

3

Total enrollment

73,840

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 4 of 4 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
DNX-24012
TTFields concomitant with modFOLFIRINOX1
Zejula1
Evaluate the effectiveness of current Human Papillomavirus (HPV) vaccination and screening programs in reducing cervical cancer incidence in Spain.1

Next readouts

  • 2026-01
  • 2027-03
  • 2027-12-31
  • 2029-05

Top conditions

  • Obesity11
  • Overweight and Obesity6
  • Overweight6
  • Surgery4
  • Breast Cancer4
  • Microbiota3
  • Difficult Intubation3
  • Insulin Resistance3

Frequently asked questions about Clinica Universidad de Navarra, Universidad de Navarra

How many clinical trials does Clinica Universidad de Navarra, Universidad de Navarra have on ClinicalTrials.gov?
Clinica Universidad de Navarra, Universidad de Navarra is listed as the lead sponsor on 159 clinical trials in ClinicalTrials.gov, 34 of which are currently active (recruiting, enrolling, or ongoing).
How many of Clinica Universidad de Navarra, Universidad de Navarra's trials are in Phase 3?
3 of Clinica Universidad de Navarra, Universidad de Navarra's trials are in Phase 3, spread across 4 active drug programs.
What therapeutic areas does Clinica Universidad de Navarra, Universidad de Navarra focus on?
Clinica Universidad de Navarra, Universidad de Navarra's most-studied conditions on ClinicalTrials.gov are Obesity, Overweight and Obesity, Overweight, Surgery, Breast Cancer.
When are Clinica Universidad de Navarra, Universidad de Navarra's next clinical trial readouts?
Clinica Universidad de Navarra, Universidad de Navarra has 4 upcoming primary-completion readouts tracked here; the soonest is “Study for Prevention of Cervical Cancer in Spain”, expected around 2026-01.